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FOREWORD
The Life Sciences Research Office (LSRO), Federation of
American Societies for Experimental Biology (FASEB), provides
scientific assessments of topics in the biomedical sciences.
Reports are based upon comprehensive literature reviews and the
scientific opinions of knowledgeable investigators engaged in work
in specific areas of biology and medicine.
This technical report was developed for the National
Aeronautics and Space Administration (NASA) in accordance with
the provisions of Contract NASW 3616. It was prepared and edited
by John M. Talbot, M.D., Senior Medical Consultant, LSRO, with the
advice and assistance of Herbert L. Borison, Ph.D., Professor of
Pharmacology, Dartmouth Medical School.
The LSRO acknowledges the contributions of the investi-
gators and consultants who assisted with this study. The report
reflects the opinions expressed by members of an ad hoc study
group that met at the Federation on September 13 and 14, 1982.
The study participants reviewed a draft of the report and their
various viewpoints were incorporated into the final report. The
study participants and LSRO accept responsibility for the accuracy
of the report; however, the naming of these individuals in Section
VIII does not imply that they specifically endorse each study
conclusion.
The report was reviewed and approved by the LSRO Advisory
Committee (which consists of representatives of each constituent
Society of FASEB) under authority delegated by the Executive Com-
mittee of the Federation Board. Upon completion of these review
procedures, the report was approved and transmitted to NASA by the
Executive Director, FASEB.
While this is a report of the Federation of American
Societies for Experimental Biology, it does not necessarily
reflect the opinion of each individual member of the FASEB
constituent Societies.
) Kenneth D. Fisher, Ph.D.
Director
Life Sciences Research Office
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SUMMARY
An important part of NASA's Biomedical Research Program
focuses on space motion sickness, a disorder whose adverse effects
on the well-being, effectiveness, and safety of spacecrew members
justify extraordinary efforts to resolve the problem.
NASA astronauts and flight surgeons did not report any
instance of frank space sickness during the Mercury and Gemini
missions; however, in retrospect, the anorexia and diminished food
intakes noted by some of the Gemini crews were suggestive of early
manifestations of space sickness. The disorder was reported in
the crews of Apollo 8, 9, 15, and 17, and five of the nine crewmen
who participated in the three, three-man Skylab missions experi-
enced some degree of space sickness while in the command module or
in the workshop. Soviet cosmonauts' experiences with the disorder
have been closely similar to those of the astronauts, and the com-
bined frequency of U.S. and U.S.S.R. instances of space sickness,
on a per crew member basis, approximates 50%.
Space sickness is likely to occur and impair crew well-
being and performance during the initial 2-5 days of a mission,
during which habituation takes place, resulting in tolerance for
the causative stimuli. Thus, space sickness is highly significant
during the first few days of spaceflight, a factor of some concern
in all manned spaceflights, but especially in missions of relatively
short duration such as those in the Space Shuttle program.
Space sickness is generally regarded as a variant of the
more common type of motion sickness. However, the provocative
stimuli must be somewhat modified from those that cause ordinary
motion sickness because the spacecraft and astronauts in orbital
flight are in continuous free fall and are, therefore, in a state
of weightlessness. Moreover, the accelerations resulting from
motions of the spacecraft during stable flight are described as
trivial. Head and body movements in combination with the influ-
ence of weightlessness are thought to be the main sources of the
stimuli that induce space sickness.
Development of a widely accepted, scientific definition
of space sickness is hampered by a serious lack of data on the pre-
cise causal stimulus or stimuli and on the basic biologic mechanisms
involved in the genesis of, and habituatlon to, the disorder. The
same may be said for ordinary motion sickness except that for it,
the initiating stimuli have been reasonably well documented. As a
result of critical gaps in knowledge, research continues to be
formulated on the basis of theory and hypothesis. The most popular
theories include sensory mismatch, sensory conflict, and sensory
overstimulation and overflow. While these theories appear basi-
cally logical, they fail to identify the precise, adequate stimulus
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for space sickness, nor do they explain fundamental mechanisms
involved in translating the cause into such responses as nausea,
vomiting, and habituation.
With the exception of drugs, promising approaches toward
prevention and control of space sickness have not led to practical
countermeasures; for example, means of identifying resistant indi-
viduals and vestibular adaptation training. Autogenic feedback
(biofeedback) training of aircrew members appears to be a prac-
tical method of dealing with air sickness, but whether it may be
practical for astronauts remains to be demonstrated. Thus, at
present, NASA uses prophylactic and therapeutic anti-motion sick-
ness drugs, which have proved useful during some, but decidedly
not all, space missions. Unfortunately, their potential effective-
ness for preventing or controlling space sickness cannot, as yet,
be predicted on the basis of preflight tests. Nevertheless, the
search for improved anti-motion sickness drugs should continue as
a key element in NASA's research program.
Aside from a possible fortuitous breakthrough in counter-
measures, satisfactory solution to the problem of space sickness
will depend upon identification of its cause or causes as well as
discovery and elaboration of the basic mechanisms that mediate the
syndrome and the associated processes of habituation. Key ques-
tions include whether the vestibular apparatus is indispensable to
the space sickness response, and which factors determine individual
susceptibility or tolerance.
Major, essential data are unavailable for explaining the train
of events that starts with exposure to the causal stimulus, moves
into the stage of acute symptomatic response, initiates con-
comitant processes of adaptation and habituation, and, postflight,
reverses itself during reaccommodation to the terrestrial environ-
ment. Much greater emphasis should be placed on generating
research in those disciplines, in addition to vestibular physio-
logy, that offer promising approaches such as the anatomy, bio-
chemistry, pharmacology, and endocrinology of the reflex circuits
involved and the use of some of the more recent investigative
methods of neuroscience. Such emphasis should aid in broadening
the research program and expediting discovery of such essentials
as the key neuronal circuits involved, their associated receptors,
transmitters, and modulators, and the determination of the indispen-
sible anatomic and humoral elements in the reflex pathways of space
and motion sickness, and their biologic mechanisms.
This report contains a summary review of space and motion
sickness, comment on the current and projected NASA research pro-
gram, and the conclusions and suggestions of the ad hoc Working
Group. The frame of reference for the report is ground-based
research; however, members of the Working Group acknowledge the
extreme importance of acquiring certain critical data from inflight
studies. Thus, there is no intended implication of detracting from
the importance of current and future plans for inflight experiments.
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I. INTRODUCTION
Manned space missions have been spectacular in their
accomplishments and reassuring in their demonstration of an
absence of permanent untoward biomedical effects. Indeed, no
manned mission, once launched, has had to be aborted because of
human factors. However, it is well known that exposure to the
space environment does result in a number of unusual biomedical
effects. These have been described by Berry (1974), Calvin and
Gazenko (1975), Gazenko et al. (1981), Genin and Egorov (1981),
and Johnston and Dietlein (1977).
Space motion sickness is the only adverse effect of space
flight that has significantly impaired crew effectiveness during
flight. It is typically reported during the initial 1-5 days in
orbit, and it appears to be related to moving about and attemping
to perform complex tasks in the spacecraft (Daunton, 1982). Data
from the Apollo and Skylab programs indicate the onset of symptoms
occasionally occurred as early as 2 hours after launch, and the
manifestions disappeared within 2-5 days post-launch (Graybiel
et al., 1977). The reported combined prevalence of the disorder
in U.S. and Soviet manned space flights approximates 50 percent of
personnel in all flights since the Gemini program (Cramer, 1982).
The manifestations have ranged from mild feelings of gastric aware-
ness and malaise to moderately severe nausea and vomiting (Graybiel,
1980; Homick, 1979; Ntcogossian and Pool, 1982; Pool et al., 1982;
Yakovleva et al., 1981). Associated phenomena have sometimes
included spatial illusions and a group of manifestations called the
sopite syndrome, which is characterized by yawning, somnolence,
indifference toward mental and physical work, and nonparticipation
in group activities (Graybiel and Knepton, 1976). This is not unlike
the behavior associated with nausea and vomiting from other causes
unrelated to motion sickness; for example, radiation sickness.
The causation of space sickness is not well defined, and
a practical understanding of its nature, which is urgently needed for
operational purposes, is further clouded by lack of exact informa-
tion on its occurrence and lack of data on the biologic mechanisms
involved in its genesis. The term itself may be somewhat misleading
in that the motion component, as it may occur in a spacecraft,
requires improved definition. For example, the passive accelera-
tions resulting from motions of the spacecwaft in stable flight have
been described as trivial (Graybiel, 1975); on the other hand,
accelerations resulting from movements of head and body during flight
can be large and appear to contribute to the induction of the syn-
drome (Graybiel et al., 1977; Matsnev and Homick, 1981), but these
would not ordinarily induce symptoms on the ground. To avoid con-
fusion with "motion sickness" as a terrestrial phenomenon, the
emetic syndrome that occurs in space flight is frequently referred
to as "space sickness."
Among the approaches that have been investigated for man-
aging the problem are prophylactic and therapeutic medications,
preflight vestibular adaptation training, identification of suscep-
tible and resistant individuals, restriction of head and body move-
ments, and autogenic feedback (biofeedback) training. With the
partial exception of drugs, none of these efforts has led to prac-
tical applications for space flight. Thus, NASA has relied mainly
on the use of anti-motion sickness drugs, which have been reported
to be effective in some cases for prevention or treatment, but not
an "ideal" solution (Graybiel et al. , 1977).
The substantial evidence that space sickness may commence
as early as 2-3 hours after launch and is prevalent during the
first 5 days of space flight is particularly relevant to the U.S.
Space Transportation System (Shuttle) program in which 4 days
represent between one-third to one-half of the time duration of
each projected mission.
There is considerable anecdotal information available on
space sickness. Additional data on its cause and mechanisms, adap-
tation and habituation, individual susceptibility, and practical
methods of prevention and control are needed. To aid in its future
research program planning, NASA requested that the Life Sciences
Research Office (LSRO) of the Federation of American Societies for
Experimental Biology (FASEB) review the subject of space sickness,
including available knowledge, the current and projected NASA pro-
gram of ground-based research, data that are critically needed,
and types of investigations that should be considered in NASA's
future program of ground-based research. This has been done with
the assistance of an ad hoc group of prominent scientists, whose
names are listed in Section VIII.
II. OBJECTIVES AND SCOPE OF THE STUDY
The objectives of the LSRO study of space sickness are:
(i) to review extant knowledge of the subject and iden-
tify significant gaps in essential knowledge; and
(2) to examine NASA's current and projected research
program and formulate suggestions to NASA for future
research.
The main sources of information for the study were (a)
the members of the ad hoc Working Group; (b) the scientific and
technical literature; (c) unpublished data from the U.S. and
Soviet space programs; and (d) the NASA Research and Technology
Objectives and Plans (RTOPs) and Research and Technology Resumes
(RTRs) on space sickness and related biomedical problems of
space flight.
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III. A SYNOPSIS OF SPACE AND MOTION SICKNESS
A widely accepted, scientific definition of motion sick-
ness does not exist, primarily because of a lack of understanding
of its etiology and mechanisms. However, its signs and symptoms
have been well documented as have the types of motions and other
stimuli associated with the syndrome. Chinn and Smith (1955),
Graybiel (1973; 1975), Money (1970), Reason and Brand (1975), and
Tyler and Bard (1949), have prepared excellent reviews of motion
sickness. Prevailing concepts of the physiology and pharmacology
of vomiting are reviewed by Borison and Wang (1953).
Knowledge of the biologic mechanisms of motion sickness
and its spaceflight version is insufficient to allow precise con-
trol via such potentially useful means as preselection of resis-
tant individuals and preflight habituation* to unconventional
motion stimuli (Homick, 1979). Anti-motion sickness drugs offer a
partial, but not an optimal, remedy for prevention and control of
symptoms.
Two hypotheses have generated much of the current basic
research on space sickness: the more widely acknowledged sensory
conflict or sensory mismatch hypothesis (Reason, 1969; 1978) and
the labyrinth fluid imbalance model, based on the fluid shift con-
cept (Barrett and Lokhandwala, 1981; Parker, 1977; Tonndorf, 1982;
Wolfe et al., 1981). However, despite substantial efforts to elu-
cidate the maladaptation phenomenon which occurs upon exposure to
the weightless state, the mechanisms underlying space sickness
remain largely unexplained.
* In this report, "habituation" is used, instead of "adaptation"
to indicate the decline in response with repeated exposures to a
novel stimulus (Collins, 1974; Guedry, 1974; J_ger and Henn,
1981; Kandel, 1977). Habituation is said to occur in the central
nervous system as distinct from sensory adaptation, which takes
place in the sensory end organ. (For example, see Taglietti
et al. 1977). In a relatively narrow sense, sensory adaptation
may be regarded as a temporary decline in response that can occur
during the first, steady exposure to a novel stimulus. Habitua-
tion can be described as specific for a particular stimulus and
as a relatively long-lasting phenomenon as contrasted with such
temporary effects as fatigue and sensory adaptation (Thorpe,
1974). However, many authors prefer the term, adaptation, to
indicate the process whereby subjects become tolerant to nauseo-
genic motion stimuli following repeated exposures.
A. DEFINITION AND NATURE OF MOTION AND SPACE SICKNESS
Space sickness is generally regarded as a variant of the
more common types of motion sickness (Daunton, 1982; National Aero-
nautics and Space Administration, 1982). It exhibits the cardinal
signs and symptoms of ordinary motion sickness (Benson, 1977;
Graybiel et al., 1977), and responds to anti-motion sickness drugs
favorably in some instances. On occasion, it has been sufficiently
disturbing to require temporary reduction in the scheduled activi-
ties of the astronauts (Graybiel et al., 1977), and has caused
major concern of both U.S. and Soviet space authorities (Heaney,
1974; National Aeronautics and Space Administration, 1982; Soffen
and Gazenko, 1981). After about 2-5 days in orbital flight, dur-
ing which a process of habituation takes place, most individuals
become immune to further space sickness during a given mission.
However, symptoms of space sickness persisted "for a long time"
during the adaptation period of one crew member in the 96-day
Salyut-6 mission, and the commander of the 140-day Salyut-6 mis-
sion experienced "mild vestibular discomfort" during head and
trunk movements on mission day 130 (Yakovleva et al., 1981). In
the first few days immediately postflight, a recurrence of signs
and symptoms is not uncommon when ordinary motion stimuli are
introduced by head and body movements and changing from the supine
to the vertical posture (Homick 1979; Yakovleva et al., 1981).
The following manifestations of motion sickness were
listed by Chinn and Smith (1955): anorexia, drowsiness, pallor,
epigastric awareness, malaise, cold sweat, nausea, vomiting, and
retching. In addition, salivation, headache, increased intestinal
peristalsis, fatigue, and mental depression had been observed.
Chinn and Smith (1955) pointed to the marked variability among sub-
jects, of the sequence, number, and intensity of symptoms, which
clouded the issue of identifying firm criteria of motion sickness.
Graybiel (1969) considered that the syndrome represented "epiphe-
nomena" resulting from receipt of unnatural stimuli by vestibular
organs and in higher cortical centers not normally characterized
as vestibular receiving areas. Money (1970) described motion sick-
ness as a malady caused by certain kinds of motions and charac-
terized by such signs and symptoms as malaise, pallor, cold
sweating, nausea, and vomiting. Motion sickness was considered to
be present whenever any of the signs and symptoms was evoked by
motion.
The manifestations of space sickness may include mild
gastric or epigastric awareness, pallor, cold sweating, sali-
vation, nausea, and vomiting (Matsnev and Homick, 1981; Money,
1970). The sopite syndrome, featuring drowsiness, indifference
toward mental and physical activity, weakness, and social with-
drawal may predominate in some instances (Graybiel and Knepton,
1976; Matsnev and Homick, 1981).
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Experience has shown that space sickness is likely to
impair crew performance and wel!-being during the initial few days
of a mission. However, the tolerance of crews to provocative
stimuli progressively increases with time in orbit, and after a
few days, they are no longer disturbed by head movements or by
cross-coupled (Coriolis) stimuli which induced sickness preflight.
Thus, space sickness may be highly significant during the first
few days of space flight, a factor of some concern in all manned
space flights, but especially in missions of relatively short
duration such as those contemplated for the Space Shuttle.
B. OCCURRENCE
NASA astronauts and flight surgeons did not report any
instance of space sickness during the Mercury and Gemini missions
(Table i); however, the anorexia and diminished caloric intakes
noted by some of the Gemini crews were suggestive of early manifes-
tations of space sickness (Dietlein, 1977). Until the Skylab mis-
sions (May, 1973), a total of nine American and four Soviet crew-
men experienced space sickness as well as other symptoms considered
to be of vestibular origin during orbital flight (Graybiel et al.,
1977). Individual members of the crews of Apollo 8, 9, I0, 13, 15,
and 17 reported some manifestations of space sickness; in missions
i0, 15, and 17, the reported symptoms were said to be limited to
stomach awareness (Homick and Miller, 1975). Five of the nine
crewmen who participated in the three, three-man Skylab missions
experienced some degree of sickness while in the command module or
in the workshop (Table i). Parker (1980) noted that 14 of 34
astronauts who participated in the Apollo and Skylab programs
experienced space sickness (see Table 2).
In their report on vestibular function of the crews of
the 96- and 140-day Salyut missions (MC-I and MC-II), Yakovleva et
al. (1981) described "vestibular discomfort" consisting of vertigo
and mild nausea in both MC-I crewmen when they moved their heads.
The authors noted that the habituation period was characterized by
violent but brief (3 days) reactions in the commander and that the
flight engineer experienced less marked reactions that persisted
for a "long time" during the habituation period. Details of the
reported reactions were not presented. Postflight, the commanders
of both Soviet expeditions presented, in addition to statokinetic
disorders, "marked vestibulovegetative manifestations including
vertigo, nausea, and retching, which were particularly intensive
when moving the head and changing to the vertical position"
(Yakovleva et al., 1981) (see Table 3).
Tolerance to motion varies markedly among individuals and
even in the same individual under the influence of different kinds
of motion stimuli (Reason and Brand, 1975). Most normal persons
can be made motion sick provided the motion stimuli are applied long
enough and are of sufficient intensity. The rate of occurrence of
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Table I. Space Sickness During U.S. Manned Space Flight Programs
Number Incidence of
Program of Reported
Crewmen Symptoms
Mercury 6 0
Gemini 20* 0
Apollo 33* lIT
Skylab 9 5
ASTP§ 3 0
STS_ 12 6
* Includes 4 crewmen who flew twice during program.
Includes 1 crewman who experienced symptoms on both of two
flights.
§ Joint U.S.-U.S.S.R. Apollo-Soyuz mission.
Space Transportation System/Shuttle Orbiter.
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Table 2. Space Sickness*
Probable variant of terrestrial motion sickness
Characterized by:
Infli_ht
o Onset shortly after beginning to move about in weight-
lessness
o Symptoms aggravated by movement and persist 2-5 days
o Illusions may be encountered with these movements;
spatial disorientation and illusions minimal and of no
operational significance
o Nausea, cold sweating, pallor, vomiting
o Crew performance and mission timelines occasionally
disrupted
o After adaptation, inflight resistance to motion stimuli
is high
o Anti-motion sickness drugs are the only therapy used to
date; efficacy has been limited
Postflight
o Isolated symptoms of motion sickness apparently induced
by recovery ship motion
o Temporary ataxia and postural dysequilibrium
o No significant illusions or disorientation
Based on Skylab:
o About 50% of crew members will be symptomatic
o Perhaps 15% will be frankly ill
o Incidence appears related to movement within spacecraft
o Medications are useful but not completely effective
o Ground-based tests cannot yet meaningfully predict who
will become sick
Experience on STST missions 1 through 5 was consistent with the
above data except that manifestations of the sopite syndrome
(Graybiel and Knepton, 1976) appeared to be more prevalent than
in prior NASA programs.
Source: unpublished material from Johnson Space Center workshop
on space motion sickness, June 1982, based mainly on experiences
of U.S. astronauts.
Space Transportation System, Shuttle flights.
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Table 3. Observations from U.S.S.R. Program*
PREFLIGHT
o "Active" and "passive" vestibular training technics used
with all cosmonauts
o 6 ° Head-down tilt during sleep used as fluid shift condi-
tioning technic
o Ground-based tests do not correlate well with inflight
symptoms
o Parabolic flight reasonably good predictor of inflight
symptoms
INFLIGHT
o Space sickness experienced by 40-45% of cosmonauts
o Main symptoms are sweating, salivation, dizziness,
nausea and vomiting
o In all cases symptoms aggravated by head movements
o Periods of adaptation vary from one to several days
o Many crewmen experienced various illusions of body tilt
and visual displacement
o No quantitative vestibular response measurements
o Countermeasures included:
o Antihistamine anti-motion sickness drug
o Voluntary restriction of head movements
o Mechanical devices (elastic cap_ and pneumatic waist
and thigh cuffs)
POSTFLIGHT
o Motion sickness symptoms (exacerbated by head movements)
seen in some crewmen
o Ataxia experienced by most crewmen
o Hypo- and hyper-reflexia of otolith function (ocular
counterrolling)
o Increased canal reactivity (cupulogram)
o Tendon hyper-reflexia
* Source: Unpublished material from Johnson Space Center workshop
on space motion sickness, June 1982.
Imparts mechanical load to cervical muscles and restricts head
movement.
i0
at least one episode of airsickness in military aviation trainees
was reported at 10-18% of student pilots and 66% of student navi-
gators; the "washout" rate was about 1% for pilots and 5% for navi-
gators because of intractable motion sickness (Money, 1970). A
striking fact is that many individuals demonstrate high resistance
to motion sickness, and, as was noted above, at least 50% of U.S.
astronauts have reported no signs or symptoms of space sickness.
As has often been stated, one key to solving the problem of motion
and space sickness may be to discover the source of tolerance in
resistant individuals.
Thus, space sickness is a temporary disorder with manifes-
tations essentially identical with those of ordinary motion sickness,
that affects approximately 50% of astronauts, begins as early as 2
hours following launch, and usually disappears after 2-5 days in
orbit.
C. CAUSE AND MECHANISMS
Exposure in a vehicle or test apparatus to unconventional
types, patterns, and intensities of motion is generally regarded
as the precipitating factor in motion sickness. Even motion of
the visual surround as perceived, for instance, in viewing a
motion picture of Earth and sky taken from a maneuvering aircraft
may induce symptoms of motion sickness in immobile, susceptible
individuals. Another variant of motion sickness is simulator
sickness, which has been observed in individuals following training
sessions in ground-based flight simulators (Crosby and Kennedy,
1982).
In space flight, the precipitating factor appears to be
motion; that is, movements of the head or body (Graybiel et al.,
1977; Matsnev and Homick, 1981). However, the movements that are
associated with space sickness include the ordinary movements of
head and body that in the normal gravity environment on Earth do
not elicit symptoms. With reference to the spacecraft, Graybiel
(1975) noted that, except during launch, programmed or unprogram-
med maneuvers in orbit, and reentry, the passive, angular accelera-
tions produced by the spacecraft in stable flight are trivial from
a physiologic standpoint. However, some U.S. as well as Soviet
spacecraft have been known to rotate slowly inflight.
Thus, a key question about the etiology of space sickness
is: how does weightlessness influence the occurrence and nature
of the disorder? An interesting associated question is: can
weightlessness evoke the syndrome in the absence of head and body
movements? Most reports indicate that head and body movements are
necessary components in the etiology of space sickness (Benson,
1977; Graybiel et al., 1977; Matsnev and Homick, 1981; Yakovleva
et al., 1981). Whether immobilization of the head and body during
space flight would prevent the disorder has not been scientifically
II
tested. Nevertheless, the absence of space sickness in the
Mercury and Gemini programs has been attributed to the relative
immobilization of the astronauts imposed by the confined crew
spaces and the wearing of movement-impeding space suits and
helmets (Berry, 1973; Dietlein, 1977; Homick, 1979).
Several factors that may bear on the causation of space
sickness include the functional adequacy of the vestibular appa-
ratus, integration with other sensory inputs, and possible altera-
tions of sensory and motor programming in the zero-G environment.
Money (1970) pointed out that most theories on the nature of motion
sickness were in one of two categories: a discord or confusion in
sensory inputs, or overstimulation resulting in "spillover" of
impulses from centers of equilibration to centers that can generate
manifestations of motion sickness. In his view, neither category
is convincingly supported by scientific evidence.
Reason (1978) considered that a mismatch between the
information received from the spatial senses and that in the
neural store from past experience led to symptoms of motion sick-
ness. In other words, a maladaptation occurs when the neural
store is at variance with _he prevailing sensory input resulting
from exposure to an unnatural motion environment. An essential
component of the theory is an intact, functional vestibular sys-
tem. In this regard, it is noteworthy that people who lack a func-
tional vestibular apparatus do not get motion sick. Whether they
are susceptible to space sickness is unknown.
Overstimulation of the vestibular end organ by exposure
to vigorous motions, resulting in an excessive response in the
vestibular nuclei with "spillover" or "radiation" into adjacent
neural centers has been suggested as a pathogenetic mechanism for
motion sickness (Brooks, 1939; Desnoes, 1926; Gillingham, 1965;
Steele, 1963). However, this hypothesis does not account for the
absence of sickness during lively horseback riding, for example.
According to Graybiel (1975), motion sickness represents:
...a constellation of delayed epiphenomena
(mainly the signs and symptoms of motion
sickness--ed.) precipitated by repetitive
vestibular sensory inputs that are either
abnormal or (if normal) encounter an abnor-
mal integrative pattern. The immediate origin
of cardinal symptoms is in nonvestibular sys-
tems; hence, first-order responses (at least)
must reach cell groups via preferential path-
ways (presumably in the brain stem reticular
formation) not used under natural stimulus
conditions.
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Certain features of the theory were summarized by Homick (1979):
The majority of research in progress to define
the etiology of space motion sickness is gener-
ally based on the premise that the syndrome is
the overt manifestation of unresolved sensory
conflict. In all likelihood, modifications in
otolith behavior which occur during the first
few hours in weightlessness are a primary
factor in creating sensory conflict. The con-
flict may be in part intralabyrithine in ori-
gin. That is, the normal synergy that is
thought to exist between the semicircular
canals and otoliths may be disrupted, thus
resulting in modified neural outflow. Also, it
is probable that intermodality conflict invol-
ving the visual, vestibular and the touch, pres-
sure and kinesthetic senses occurs. The net
result may be an inability of the central
nervous system to properly integrate the mis-
matched sensory influx. Adaptive processes in
the central nervous system presumably occur as
evidenced by the gradual and complete recovery
from symptoms of motion sickness.
The hypothesis that labyrinthine fluid imbalances may
result from the well-documented cephalad shifts of blood and body
fluids in zero-G and may cause abnormal vestibular function leading
to symptoms typical of motion sickness originated following the
Skylab program, and is still viable (Tonndorf, 1982; Wolfe et al.,
1981). Some additional support for the concept is based on the
knowledge that acute changes of air pressure in the middle ear can
induce vertigo (Benson and King, 1979). Another suggestion is
that fluid shifts may result in decreased circulating levels of
isorenin-angiotensin, leading to direct effects on the chemorecep-
tor trigger zone (Barrett and Lokhandwala, 1981).
Treisman (1977) postulated that the mechanisms of motion
sickness function in the physiologic responses to certain poisons.
Sometimes called the evolutionary theory, it suggests that the dis-
equilibrium, malaise, nausea, vomiting, and other manifestations
of motion sickness evolved as a pattern of response to such life-
threatening situations as the ingestion of foodborne neurotoxins,
and that this response registered in survivors as a warning against
future exposure to such poisonous substances. Money and Cheung
(1982) tested Treisman's hypothesis by injecting labyrinthectomized
dogs with four, and later, five emetic poisons. Removal of the
vestibular apparatus resulted in marked impairment of the vomiting
response to lobeline, levodopa, and nicotine, but not to pilocarpine
or apomorphine. They concluded that the vestibular apparatus is
part of the normal mechanism for the emetic response to certain
poisons and that Treisman's theory had merit.
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In formulating their conclusions, Money and Cheung (1982)
cited the basic report of Wang and Borison (1952) who developed a
general physiologic method for differentiating between emetic sub-
stances that are peripherally or centrally active. Wang and
Borison (1952) demonstrated the existence of an emetic chemore-
ceptor trigger zone in the floor of the fourth ventricle, corre-
sponding anatomically to the area postrema. They concluded that
the medullary emetic mechanism consisted of two anatomically close
but functionally separate parts: first, an emetic center near the
fasciculus solitarius and underlying reticular formation, and
second, a chemoreceptor trigger zone. Citing a report of Wang and
Chinn (1952) which showed that dogs became resistant to swing sick-
ness after ablation of the trigger zone, Wang and Borison (1952)
suggested that further validation of this effect might support the
concept that vestibular impulses elicited by motion traverse the
nodulus and uvula of the cerebellL_n and the trigger zone, finally
reaching the medullary vomiting center. They suggested that such
studies could prove valuable in determining the mode of action of
anti-motion sickness drugs.
Parker (1980) noted that most investigators of the vesti-
bular system tend to believe that space sickness is the result of
sensory mismatch; that is, the disparity between orientation inputs
received from different receptors. Currently, many investigators
regard the sensory conflict theory as the most viable; however, it
remains ill-defined in terms of physiologic mechanisms. Members
of tilead hoc Group regarded the sensory conflict theory as a con-
cept that may be useful in planning research and designing neuro-
physiologic and neuroanatomic experiments, but that it is insuffi-
cient, at its present state of development, to explain any under-
lying mechanisms of space sickness.
In summary, exposure of an unaccustomed subject to cer-
tain types of unusual motions is the common cause of motion sick-
ness. Space sickness is thought by many experts to result from
exposure to a combination of head and/or body movements and weight-
lessness, but this has not been fully documented. The mechanisms
of motion and space sickness are unknown; hence, current investiga-
tions are based mainly on theories involving neural mismatch, sen-
sory conflict, or certain postulated effects of the cephalad shift
of blood volume and body fluids that occurs in zero-G.
D. COUNTERMEASURES
In view of the incomplete understanding of the underlying
mechanisms and the pathogenesis of motion sickness and its space
sickness counterpart, NASA currently has little option for dealing
with the problem except to rely on anti-motion sickness drugs and,
possibly, to assign to key positions in space crews those who have
demonstrated resistance to space sickness on previous missions.
Preselection of individuals who are resistant to motion sickness,
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and preflight habituation to provocative vestibular stimulation on
the theory that this would prevent or ameliorate space sickness or
hasten the habituation process appear logical and desirable. For
instance, human habituation to provocative vestibular stimulation
has been demonstrated in ground-based studies. However, the ques-
tion whether the tolerance to ground-based or aircraft-based vesti-
bular stimulation will transfer to the spaceflight situation and
will influence susceptibility to space sickness has not been
answered, although Soviet authorities seem convinced that pre-
flight exposure to vigorous aerobatic maneuvers offers some protec-
tion against space sickness.*
Among the approaches that are being investigated in
regard to preventing or treating space sickness are prophylactic
and therapeutic medications, vestibular adaptation training, pre-
selection of resistant individuals, restriction of head and body
movements, and autogenic-feedback (biofeedback) training. However,
since research on these several approaches has not yet provided
practical methods for spaceflight, NASA has relied mainly on pro-
phylactic and therapeutic use of drugs during actual space mis-
sions. The need for expanded research emphasis on alternate
approaches is underscored by the observations that prophylactic
and therapeutic use of drugs is not, by itself, reliably and com-
pletely effective, and carries with it the problem of adverse side-
effects.
Anti-motion sickness drug evaluations in ground-based
studies and in aircraft have shown that agents possessing central
anticholinergic actions and drugs that augment central sympathetic
activity are effective against acute motion sickness (Chinn and
Smith, 1955). Currently, NASA uses the orally administered combi-
nation of scopolamine (0.35 mg) and dextroamphetamine (5.0 mg) for
premedication or treatment. During sleep periods, promethazine
(Wood, 1982) or diazepam (Olson, 1982) has been suggested. The
NASA strategy for anti-motion sickness medication includes pre-
flight evaluation of drug effectiveness against the effects of
provocative vestibular stimulation and observation of side-
effects. Astronauts scheduled for space missions are treated
according to the following plan: (i) premedicate if there has
been no previous space flight experience, or if there is a posi-
tive history of space sickness; (2) do not premedicate if there is
no history of space sickness during previous flights; (3) treat
inflight if symptoms occur.*
* Unpublished data presented during the meeting of the LSRO ad hoc
Working Group on Space Motion Sickness, September 13-14, 1982,
at FASEB Headquarters, Bethesda, MD.
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Wood and Graybiel (1972) reported that scopolamine was
the most effective individual drug and scopolamine-amphetamine the
most effective drug combination for preventing motion sickness in
volunteer subjects during controlled tests in the Pensacola Slow
Rotating Room. However, in subsequent tests in the same facility,
the combination of promethazine (25 mg) and ephedrine (25 mg) was
shown to be superior to all other drugs in that particular provoca-
tive environment (Graybiel et al., 1975; Graybiel and Knepton, 1977;
Johnson et al., 1976). In addition, these studies contributed
further knowledge of the marked biologic individuality of drug
responses, reemphasizing the need for individual pretesting for
antinauseant efficacy and for side-effects.
A non-pharmacologic countermeasure that holds promise is
autogenic feedback training (Cowings and Toscano, 1982; Toscano
and Cowings, 1982). This type of method has demonstrated effec-
tiveness in salvaging for flying duties a substantial number of
U.S. Air Force aircrew personnel who suffered incapacitating air-
sickness (Gardner et al., 1983). Whether it may prove to be effec-
tive and practical for spacecrew members remains to be demonstrated.
NASA's research plans include consideration of this question.
Attempts were made to preadapt some members of the Skylab
crew to provocative vestibular stimulation by a regimen of repeated
series of head movements with subjects seated in a rotating chair,
and by weekly sessions of aerobatics in high performance aircraft
(Skylab 4 crew members) (Homick, 1979). Although these procedures
appeared to reduce susceptibility to motion sickness induced by
ground-based Coriolis accelerations, there was no evidence of their
possible benefit during the space flight missions of the Skylab
program. Nevertheless, the concept of pre-space flight vestibular
habituation using ground-based or airborne methods has not been
exhausted.
Soviet space medical investigators have tested several
physical devices including pneumatic cuffs on the thighs, lower
body negative pressure, and a special headgear. They have
reported beneficial results in management of space motion sickness
from the use of the headgear, which they call the prophylactic
cervical support. It consists of a soft cap attached to the
shoulders by adjustable rubber constraints. The device imparts a
mechanical load on the cervical spine and the occipital-cervical
antigravity muscles, and also tends to limit head movements. It
is said to have prevented illusory sensations and to have diminished
the symptoms of space sickness (Matsnev and Homick, 1981). It is
understood that development and test of the device are continuing
in the U.S.S.R., and it is listed as a possible item for test in
the U.S. space motion sickness research and technology program
(National Aeronautics and Space Administration, 1982).
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Thus, NASA currently relies on the prophylactic and thera-
peutic use of anti-motion sickness drugs, procedures that have
proved only partially effective in preventing or controlling the
symptoms of space sickness. Identification of resistant individ-
uals, preflight vestibular habituation, transferability and
enhancement of habituation, autogenic feedback training, devices
to restrict head movement and load the cervical muscles, and alter-
nate types of drugs are being investigated in hopes of finding
practical, effective methods of avoiding, preventing, or control-
ling space sickness.
17
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IV. THE NASA RESEARCH AND ANALYSIS PROGRAM IN SPACE
MOTION SICKNESS
Of the eight major problems addressed by NASA's Bio-
medical Research Program, space sickness currently has the highest
priority (Soffen and Bishop, 1982). A program of research and
analysis in Space Motion Sickness is included in the Biomedical
Research Program of the Life Sciences Division at NASA Head-
quarters. Responsibility for the scientific management of the two
Research and Technology Objectives and Plans in space motion sick-
ness is assigned to the appropriate RTOP's managers at the Johnson
Space Center and the Ames Research Center. Together, the two RTOPs
managers supervise a total of 24 research tasks of which 19 are by
university grants or contracts. In addition, they conduct their own
scientific investigations of space sickness in their NASA center
laboratories.
Most of the research conducted under the two space motion
sickness RTOPs is ground-based; however, through these investiga-
tions, hypotheses are developed that must ultimately be tested in
space. The program is, therefore, closely related to the planned
series of inflight experiments on the Shuttle and Spacelab.
The FY 1983 budget for the biomedical research program in
space motion sickness approximates $2.0 million, of which $1.4
million is extramural. Both the extramural and intramural
programs undergo periodic revision in response to changes in
scientific guidance, changes in priority, the addition of new,
peer-reviewed research, and the phase-out of completed or
downgraded tasks.
Table 4 lists research recommended by two major life sci-
ences advisory groups (Bricker, 1979; Whedon, 1978), and shows, by
task number, the applicable research in the current (FY 83) pro-
gram under the two primary NASA RTOPs in space sickness. Blanks
in the table indicate no research is specifically documented under
the two RTOPs at the present time. However, not shown in the
table are tasks pertaining to certain operational and flight test
aspects of space sickness that are programmed or planned to be
carried out under separate RTOPs. It is clear, from comparison of
the scope and amount of research and development that have been
documented as necessary to resolve the problem of space sickness,
that the needs exceed the available FY 83 resources by a wide
margin. Moreover, achieving an ideal solution to the problem
requires the elaboration of etiologic and mechanistic factors that
have eluded several decades of scientific investigation.
Opinions of the members of the LSRO ad hoc Working Group
on Space Motion Sickness on the merits of the current NASA ground-
based program are based upon abstracted information in the NASA
RTOPs and RTRs, on information presented during the meeting of
September 13-14 by NASA scientists, and on their own knowledge of
19
Table 4. Correspondence between advisory group guidance* and NASA's FY 83 research and technology
program in space motion sickness
Johnson Space Center Ames Research Center
Suggested research and technology RTOP 199-20-21 RTOP 199-20-22
appllcable tasks applicable tasks
SIIORT- AND HID-TERM (<5 y)
Behavioral responses to otollthlc stlmulatlont:
lluman, ground-based and spacefllgbt 02 --
Animal, ground-based and spacefllght ....
Epldemlologyt:
Analyze astronauts' individual anti-motlon sickness
training versus space sickness experience ....bo
O Improve methods of Infllght data collectlon programmed in a --
separate RTOP
Countermeasures:
Identify susceptible and resistant Indlvlduals t 02, 09, 16 --
Antl-motlon sickness tralnlng--
Vestibular and associated sensory systems
ground-based 16 --
airborne ....
Autogenlc feedback to be programmed under I0
a separate RTOP --
Antl-motion sickness drugs t
Seek improved drugs and drug combinations 09, 16 II
Test alternate routes of administration 16 --
Improve drug delivery systems ....
Methods and facilittest:
Tile need for parabolic flight 09 09
Develop acceleration devices for use in Spacelab programmed in a programmed in a
separate RTOP separate RTOP
Develop methods to facilitate adaptation 16 --
Table 4. (cont.)
Johnson Space Center Ames Research Center
Suggested research and technology RTOP 199-20-21 RTOP 199-20-22
applicable tasks applicable tasks
LONG-TERH (>5 y)
Biologic mechanisms:
Of motion sickness and space motion sickness--
Test and elaborate current hypotheses--
Sensory conflict 04, 09 05, 22
Otollth dysfunction programmed In a programmed In a
separate RTOP separate RTOP
Altered semicircular canal response 17 15,22
Fluid shifts 03 --
Of marked differences in Individual susceptibility ....
Of adaptation to weightlessness 09 --
to Neuroanatomy and physiology of vestlhnlar systems
Vestibular end organ 05 15, 20, 22
Related spatial sensors ....
Locate second order otolithle neurons -- 06, 14, 15, 18
Physiologic organization of otoltth pathways
within vestibular nuclei -- 04
Characterize response of second order otollthlc
neurons to motion stimuli -- 14
Characterize Interactions of vestibular, visual and
other spatial-sensory inputs at level of second
order neurons 03, 09, 17 04, 05, 09, 17, 21
Extend studies of vestibular system responses and
Interactions to further stages of relevant
pathways -- 11, 141 18
Vomiting areas of bralnstem
Further Identify and characterize areas in bratnstem
Involved In vomiting -- 03, 11, 21, 23
Effects of inputs from vestibular, visual, and other
sensors on vomiting areas of bralnstem ....
Determine whether stimulation of vestlbnlo-eerebellum
areas causes vomiting -- 03, 05
* From reports of two advisory groups (Brlcker, 1979; 14hedon, 1978). Tills table is merely an example,
for NASA°s scientific advice is derived from multiple sources. The aggregate of NASA RTOPs that
Include work on space motion sickness is sufficiently comprehensive to embrace all the research
suggested in this table.
| Ilas Implications for long-term studies also.
Key to the task numbers in Table 4.
Task No. Investigator Location
Johnson Space Center RTOP #199-20-21
-02 Reschke (mechanisms) Johnson Space Center
-03 Parker Miami U., Ohio
-04 Igarashi Baylor U., Houston
-05 Correia U. Texas, Galveston
-06 Anderson U. Michigan, Ann Arbor
-09 Lackner Brandeis U., Waltham
-14 Oman MIT, Cambridge
-16 Begioanni (counter-
measures) Johnson Space Center
-17 Black Portland, Oregon
Ames Research Center RTOP #199-20-22
-03 Mehler Ames Research Center
-04 Goldberg U. Chicago
-05 Daunton Ames Research Center
-09 Young MIT, Cambridge
-i0 Cowings Ames Research Center
-11 Brizzee Tulane University
-14 Wilson Rockefeller U., New York City
-15 Perachio U. Texas, Galveston
-17 Bizzi MIT, Cambridge
-18 Graybiel MIT, Cambridge
-20 Tomko U. Pittsburgh
-21 Miller Rockefeller U., New York City
-22 Correia U. Texas, Galveston
-23 Crampton Wright State U., Dayton
-25 Norris Tulane U., New Orleans
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the space sickness problem. Most comments have been favorable in
terms of the described experiments and approaches and quality of
the investigators doing the work. Some members felt that much of
the basic neuroscience in the program is not directly related to
motion sickness so as to qualify for NASA support although they
had no quarrel with the scientific excellence of the particular
studies. This was a debatable subject on which a majority of the
Working Group were convinced that much basic neuroscience must be
accomplished before the etiology and mechanisms of motion sickness
and space sickness can begin to be reasonably understood. Conse-
quently, the majority view was that NASA's current program of ground-
based research and development serves its objectives and approaches,
is appropriate with respect to current studies, but insufficient in
level of effort. It is understood that opportunities for increasing
the level of effort of the program now exist within NASA, and the
Working Group endorses a careful expansion of the program along lines
suggested in Sections V and VI of this report.
During the deliberations of the LSRO ad hoc Working Group,
problems of space sickness associated with the Shuttle flights re-
ceived considerable publicity. NASA officials recognized the
necessity to expedite and broaden the scope of research aimed at
understanding and controlling the disorder. In this regard, NASA
conducted a workshop at the Johnson Space Center in June, 1982,
convening a group of 33 individuals including responsible NASA
research managers, staff scientists, and a number of prominent
investigators who are involved in studies of space and motion sick-
ness. A report of the proceedings has been published (Homick,
1982).
A majority of the studies and their priorities recom-
mended by the workshop subgroup on physiology are consistent with
the opinions of the LSRO Working Group. The biological systems
approach identified in the Proceedings (Homick, 1982) would offer
a particularly promising methodology for research planning and
experimental design. Similarly, the broadening of the disci-
plinary approach, the emphasis on chemical-mediating mechanisms in
the stimulus-to-vomiting sequence, and the use of interdisciplinary
teams to define the physiological correlates of the conflict and
mismatch theories and the specific linkages to the effector
mechanisms of space sickness are examples of research strategies
supported by the LSRO ad hoc Working Group on Space Motion
Sickness.
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V. OBSERVATIONS OF THE AD HOC WORKING GROUP
ON SPACE MOTION SICKNESS
For convenience of presenting the views of the Working
Group, this section is divided into five topics: (i) cause and
mechanisms, (2) peripheral sensory organs, (3) central nervous sys-
tem structures, (4) methodology, and (5) countermeasures and other
aspects. The suggested research and development are intended to
assist NASA program managers in formulating plans for future
research and technology in space sickness; however, they are also
intended to serve as examples of opportunities for interested sci-
entists to participate in NASA-supported scientific endeavors.
A. CAUSE AND MECHANISMS
i. Assessment
Many authorities seem satisfied that the cause of
motion sickness and its space counterpart is unusual acceleration
of the vestibular end organs. Although manned space flight experi-
ence strongly suggests that movements of the head are necessary to
induce space sickness (see p.ll), this has not been adequately
documented, and a fundamental question persists: "What is the
stimulus for space sickness?" Some members of the Working Group
consider the stimulus multimodal including head and body movements
which are seemingly unusual because of a lack of motor programming
to deal with weightlessness, inappropriate central interpretation
of mixed sensory inputs caused by weightlessness, and possible psy-
chic influences. The precise targets for sensing the provocative
stimuli during space flight have not been definitely established;
for example, are the otolith organs or the semicircular canals, or
both, involved?
The specific physiologic mechanisms of motion and space
sickness remain obscure. Likewise, the broader biologic significance
of motion sickness is not understood although the concept of Treisman
(1977) offers a possible evolutionary perspective (see p.13). The
Working Group discussed prevailing theories of mechanisms (see p.12),
but considered that none adequately explains the genesis of the syn-
drome.
With regard to where the emphasis should be placed on
investigative approaches to elaborating the etiology and patho-
genesis of space sickness, the comments of Chinn and Smith (1955)
are still germane:
In the onset of motion sickness, it is apparent
that the central and autonomic nervous systems
are repetitively bombarded with impulses along
afferent pathways not only from the vestibular
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organ, but, also, from other sources such as
the optic, proprioceptive, and visceral sys-
tems. The importance of these latter stimuli
are not minimized, but since motion sickness
can be prevented by interruption of vestibular
impulses (bilateral labyrinthectomy, sectioning
of 8th nerve) this pathway deserves primary
emphasis.
Further, Benson's summary statement in 1977 quoted in Bricker
(1979), may still offer the best general guidance:
The features of the sensory and autonomic dis-
turbances that have come to be called space
sickness are thus very similar to those pro-
duced by motion stimuli in a terrestrial envi-
ronment. Although similarity does not prove
that the causal mechanisms of space sickness
are necessarily the same as those of motion
sickness, in the absence of evidence to the
contrary, parsimony dictates that space sick-
ness must be considered just another form of
motion sickness.
General observations of the Working Group on the state-of-
the-art in motion and space sickness highlight the immensity and
complexity of the problem of elucidating the underlying mechanisms.
A consideration that is related to the question of the etiology of
space sickness is whether the vestibular organs do, if fact, remain
physiologically normal during space flight. There is a paucity of
reported research on the biochemistry of motion sickness. Little
is known about the neuropharmacology of synaptic mechanisms of the
sensory end organs, afferent pathways, and at the central processing
and effector sites. It is not known whether the "final" stimuli in
the reflex arcs of nausea and vomiting are neurogenic or chemogenic,
nor are the essential neural connections involved in motion sickness
fully identified.
It is known that a diversity of afferents comes from the
labyrinth, but little is known of how they are distributed to the
secondary neurons which also receive input from other sensory sys-
tems or neural structures. This impedes understanding of relation-
ships between labyrinthine responses and central processing. For
example, how valid is the assumption that an isomorphic causal rela-
tionship exists between vestibular afferent impulses from a standard
head movement and the observed neural responses in identified, ana-
tomically-linked secondary neurons? Moreover, how does concomitant
input from other sensory systems modify the fidelity of neural
transmission of afferent input by vestibular nuclei neurons? The
roles of the diencephalon and the cerebral cortex in the etiology
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of and habituation to motion sickness are essentially unknown (p.32
et seq.). For instance, the anatomic and physiologic properties
of the vestibulothalamic and vestibulocortical pathways are not
clearly understood (see review, Correia and Guedry, 1978).
Answers are needed to such basic questions as, for example:
where and how processing of normal motion-induced sensory inputs
takes place; where and by what means adaptation and habituation to
ordinary as well as extraordinary stimuli occur; what parts of the
reflex arcs or other neural structures involved in motion sickness
demonstrate plasticity in response to motion stimuli; and, at the
molecular level, how mechanical energy of deflection of hair cell
cilia is converted to electrical energy; how hyperpolarizing and
depolarizing receptor potentials are generated; and how the rest-
ing level of spontaneous discharge that appears to occur on pri-
mary afferent neurons is generated. Finally, it was noted that
few reports of interest to space sickness have come from experi-
ments in which some of the newer methods of neuroscience have been
employed (p.35, 37). Descriptions of such methods are presented
in the 1978-1982 short course syllabi on methodology published by
the Society for Neuroscience.*
It is clear that research opportunities abound for innova-
tive investigators who, it is hoped, may expand their interests to
include the problem of space and motion sickness.
2. Research suggestions
The inflight patterns of head and body movements of
astronauts should be recorded to permit objective comparison
between those who do and do not become space sick. This type of
analysis should aid in defining the cause of space sickness. In
addition, if data are available, analysis of the detailed inflight
histories of all past participating astronauts may help to define
differences between susceptible and resistant individuals, times
of onset of symptoms in relation to mission profiles, and possible
contributing events and circumstances.
Experimental technics should be developed and tested in
ground-based studies involving both animal and human subjects, in
preparation for space flight experiments to determine: (a)
whether space flight results in modification of the vestibular
sensory neuroepithelium or associated structures (Vinnikov et al.,
1979); (b) whether animals with severed vestibular nerves become
space sick; (c) whether animals whose neck movements are artifi-
cally restricted become space sick; and (d) whether space-flown
* 9650 Rockville Pike, Bethesda, MD 20814.
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animals show any swelling of the sensory epithelium. Future exten-
sions of space flight studies should include observations of other
sensory systems that are thought to be involved in the genesis of,
and habituation to, space sickness. Flight experiments will require
preliminary ground-based efforts to develop and test flight-compatible
technics and equipment.
B. PERIPHERAL SENSORY ORGANS IMPLICATED IN MOTION
AND SPACE SICKNESS
i. Assessment
Among the sensory systems that may be involved in
the initiation of space sickness, the vestibular system stands out
as the most likely candidate. Knowledge of the structural and
ultrastructural anatomic relationships and mechanical interactions
among the otoconiae, cupulae, and the hair cells is incomplete
(Dohlman 1971, 1950; Lindeman, 1969). The neurotransmitters and
chemoreceptors within the peripheral vestibular neuroepithelium
have not been adequately identified (Flock and Lam, 1974). For
instance, in mammals, the transmitters at the hair cell synapses
and at the first neuronal synapses in the vestibular pathway are
not specified. It is likely, however, that the transmitters in
question are identical to those that are being studied in the
auditory system. (For a review see Guth and Melamed, 1982).
A fundamental need in understanding vestibular function
concerns whether the semicircular canals are sensitive to gravity
(Estes et al., 1975; Goldberg and Fernandez, 1975); that is, are
the canals responsive to linear force under every day conditions
on Earth and does this relate to the generation of space and
motion sickness? A related question is whether there is any
information processing via collateralizing axons between various
components of the semicircular canals and the otolith organs
(Caston, 1970; Caston and Gribenski, 1982).
Knowledge of the origins and effects of efferent stimuli
on the vestibular end organs is conflicting (Goldberg and Fernandez,
1980; Klinke and Galley, 1974), but efferent influences may be sig-
nificant in the induction of motion sickness and in habituation.
What are the mechanisms by which efferent vestibular traffic affects
afferent vestibular activity? Does efferent input affect neuro-
transmitter synthesis in the peripheral vestibular system? What
are other trophic effects, if any, of efferent vestibular
activity? For example, are the spontaneous activity and dynamic
response characteristics of primary afferents affected by pro-
longed periods of weightlessness?
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Information is insufficient for a clear understanding of
several aspects of labyrinthine physiology such as development and
maintenance of the end organs including biochemical control of oto-
conial formation, development of accessory structures including the
cupula and otoconial membrane, and the control of endolymph produc-
tion. What is the significance, if any, of the negative calcium
balance associated with long space flights on otolith organ and
vestibular hair cell function? What regulates calcium turnover in
the otoconia? What is the role of Ca ++ in vestibular hair cell
receptor potentials?
The vascular supply of the labyrinth, its neural control,
and its effects on labyrinthine function and ionic composition of
the perilymph and endolymph have not been fully investigated
(Dohlman and Radomsky, 1968). Such studies may be useful in
further exploration of the fluid shift hypothesis of motion sick-
ness. Another problem concerns whether interactions and infor-
mation processing occur among the vestibular end organs under the
influence of multi-directional motion stimuli such as, for example,
cross-coupled angular accelerations and concomitantly acting
linear and angular acceleration. If such interactions occur, are
they reflected in the primary afferent output?
A possible site of neural adaptation in the vestibular
sensory neuroepithelium in frogs has been proposed (Taglietti
et al., 1977), but the neurophysiology, neuropharmacology, and
biophysics of the adaptive mechanisms have not been explored.
Many scientists believe the vestibular end organs remain
normal during space flight; however, there is some conflicting
evidence (Vinnikov et al., 1979). This issue has not been scienti-
fically resolved. It is an important question deserving of high
priority in future space flight experiments. Finally, the effects
of aging on the integrity of the vestibular organs and their
neural supply (Bergstrom, 1973a,b,c) and on susceptibility to
motion sickness have not been adequately analyzed despite the
existence of a reasonable literature on aspects of this subject.
This is of obvious interest to career astronauts.
2. Research suggestions
The afferent input from the vestibular organs
resulting from linear acceleration, angular acceleration, and
complex stimuli such as cross-coupled accelerations should be
identified and characterized at the single unit level. It may be
feasible to study the effects of zero-G on the functional and
structural integrity of the vestibular end organs by means of
repeated parabolic flights. For example, experimental animals
exposed to an intensive series of multiple parabolas daily for 3-6
days might offer a method of demonstrating possible structural
changes in the labyrinth. With respect to opportunities for space
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flight experiments, ground-based research and development are
needed to develop technics and equipment for measurement of vesti-
bular nerve activity. In addition, protocols should be developed
for precise acquisition and chemical fixation for histopathologic
examination of temporal bones of space-flown animals. Ideally,
some animals should be sacrificed and tissues fixed at intervals
throughout the flight; others postflight. A suitable method of
tissue fixation is by intracardiac perfusion plus local perfusion
of the inner ear.
The question of whether the semicircular canals are
gravity-sensitive should be studied in a normal, alert, chronic
preparation in a one-G environment; for example, a monkey with
chronically implanted electrodes (Keller, 1976; Louie and Kimm,
1976). Methods should be developed for investigating the inter-
actions between the receptors for linear and angular acceleration
as a step toward understanding the stimuli that are imposed by
ordinary and by unusual head and body movements in both one-G and
zero-G environments.
Stimulation of vestibular system efferents should be
investigated in relation to effects on afferent activity in alert
primates in physiologic situations in which the efferent system
may participate. _ualitative and quantitative changes, if any, in
neurotransmitter activity at various levels in t_e vestibular
system that result from efferent inputs should be determined.
Identification of the neurotransmitters in the afferent
pathways, particularly at the end organ, could lead to practical
pharmacologic studies of candidate anti-motion sickness drugs, and
possibly, of anti-vertigo drugs. In addition, further studies
should be done on the possible existence in the vestibular nerve
of postganglionic autonomic nerve fibers (Densert, 1975; Ross,
1981; Ylikoski et al., 1979). If this is confirmed, the role of
such a pathway on end organ function should be investigated.
A promising approach to continue the investigation of the
fluid shift hypothesis of space sickness would be to determine
changes in auditory threshold during cephalad shifts of blood
volume. If confirmed, such changes might suggest concurrent
changes in vestibular end organ sensitivity or function. Human
and animal subjects exposed to head-down tilt and animals exposed
to foot-to-head acceleration might be appropriate models for such
studies. In addition, inflight test of spacecrew members' hearing
may be a feasible extension of such studies.
Another basic study having significant implications for
the fluid shift hypothesis would be to demonstrate a meniere's
type resF.onse (Wolfe et al., 1981) to frequency analysis testing
of the vestibuloocular system in an astronaut during an episode of
space sickness or following recovery.
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C. CENTRAL NERVOUS SYSTEM STRUCTURES IMPLICATED IN MOTION
AND SPACE SICKNESS
i. Assessment
Pathways through the central nervous system resulting
from motion stimuli have been only partially delineated. For
instance, the pathways through the cerebellar nuclei are unknown.
In fact, the anatomic mapping of pathways and centers of response
to gravito-inertial stimulus inputs from the involved sensory
systems is only fragmentary. However, the neuroanatomy associated
with motion sickness appears to be advanced relative to what is
known of the functional significance of the defined pathways and
connections involved.
A fundamental question that indicates a need for substan-
tial additional research concerns where and how the central ner-
vous system processes motion-induced signals from the vestibular,
visual, proprioceptive, and somatosensory receptors. It is
thought that the vestibular nuclei and parts of the vestibular
cerebellum have prominent roles in such information processing,
but detailed data on this are lacking. Examples of other struc-
tures of the brain stem that have been implicated in the pathways
of response to motion-induced inputs and that may have a role in
processing include the nucleus prepositus, nucleus intercalatus,
and the nucleus of Roller. These all seem to have direct or indi-
rect connections with the vestibular nuclei and the nucleus trac-
tus solitarius as well as area postrema. Connections between the
solitary nucleus and the reticular formation in the region of the
vomiting center have also been identified. In addition, neurons
have been identified in which the cell body is located in the area
subpostrema inside the blood-brain-barrier, but outside the area
postrema. The dendrites from some such neurons extend through the
blood-brain-barrier into area postrema, and axons of such neurons
extend into the nucleus of the solitary tract. It appears pos-
sible that some such neurons may serve to monitor electrical events
or even the chemical milieu in the area postrema outside the blood-
brain-barrier and to transmit appropriate signals to the non-
gustatory part of the nucleus of the tractus solitarius which may
be involved in mediating the vomiting reflex to different types of
stimuli, including various modalities of motion. Thus, numerous
connections have been found that are of interest in relation to
motion sickness although very little is known about their func-
tions (Cottle and Calaresu, 1975; Hosoya and Matsushita, 1981;
Morest, 1960, 1967; Vigier and Portalier, 1979; Vigier and
Rouviere, 1979). Moreover, there are, at present, no adequate
models or methods of analysis for resolution of the questions on
central processing.
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Another problem, of equal importance to information proc-
essing, is the matter of habituation and adaptation to motion-
induced stimuli. The process of adaptation at the cellular level
in the vestibular nuclei, if it occurs there, or the vestibular
neuroepithelium, is essentially unknown. Similarly, the cere-
bellum is thought to have a prominent role in habituation, but
where and how it takes place are not clear. Is the plasticity in
the cerebellum or is the cerebellum merely a part of a motor loop
for other areas of the brain that may be involved in habituation?
What are the effects of ablation of parts of the cerebellum on
habituation? Are neurons that project to the cerebellum, thence
into the brain stem, inactivated by cerebellar lesions?
Some preliminary evidence suggests that an endogenous
"vomiting substance" may be an essential part of the emetic reflex
arc in motion sickness (for instance, see Daunton, 1982). An
interesting question in this regard is a possible role of the
spongiform bodies of the circumventricular organ system in the
brain ventricles (Kelly, 1982); however, there are no reports that
these organs are secretory. The possible existence of an endog-
enous vomiting substance is of interest for several reasons
including the uncertainty about whether the final afferent link in
the emetic reflex arc is neuronal or chemical (Borison and
McCarthy, 1983).
Receptors of the antimuscarinic and antihistaminic types
have been found in the vestibular nuclei (Palacios et al., 1981;
Wamsley et al., 1981); however, available information on the bio-
chemistry of the receptors and neurotransmitters in the vestibular
nuclei, as in other parts of the vestibular system, is very limited.
What other types of receptors and transmitters may be found in the
reflex arcs associated with motion and space sickness?
The effects of the brain stem reticular system on
responses to motion stimuli at the level of the vestibular nuclei
are not clearly defined and have not been carefully studied in
recent years. Is the efferent process that is associated with
motion sickness augmented by proprioception, vision, or stress?
Available information on the functions of the diencephalon and
cerebral cortex in mediating motion sickness and habituation is
meager. Motion-induced reticulocortical input followed by inhib-
itory corticothalamic outflow might influence responses to the
stimuli that cause motion and space sickness. However, decere-
bration does not prevent motion sickness or the emetic response in
some species (Money, 1970; Tyler and Bard, 1949). Novel stimuli
can generate anxiety and concomitant sympathetic activation in
species having higher cortical integration, but a majority of
experts believe that anxiety probably does not influence suscepti-
bility to, or promote, motion sickness. Nevertheless, some evi-
dence points toward anxiety as a contributing factor in airsick-
ness (Tucker and Reinhardt, 1966), and the powerful influence of
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the cerebrum over brain stem and cerebellar mechanisms (Money,
1970; Penfield and Erickson, 1941; Reason and Brand, 1975;
Robinson and Mishkin, 1968) suggests that higher cortical activity
is capable of exerting both suppressive and faoilitatory influ-
ences on motion and space sickness neural processes. Questions
remain as to exact neurophysiologic mechanisms and the extent of
such effects. A question also arises as to whether behavioral
intervention technics (see p.16) might be operative via a cortico-
thalmic-reticular, corticodiencephalic, or other mechanism and
whether such behavioral-cognitive training technics could be effec-
tive as countermeasures to space sickness and to what degree.
Other problems that need investigation concern the pos-
sible role of the deep cerebellar nuclei in producing motion sick-
ness. Neurons in these nuclei respond to motion stimuli, and the
deep nuclei have some functions related to postural responses and
the storage of balance information. For example, lesions of the
cerebellum are associated with certain long-lasting effects on eye
movement control such as periodic, alternating nystagmus, and
there is interest in whether the deep cerebellar nuclei are
involved in the habituation process, especially to inputs that
occur over long time periods. Although a great deal is known
about the function of the flocculus, relatively little is known of
other areas of the cerebellar cortex, such as nodulus and uvula,
that have prominent projections into the deep cerebellar nuclei.
Interest also concerns the possible roles of the inferior olive
and inputs via the climbing fibers and mossy fibers in motion sick-
ness and habituation. Related to these matters is the question of
how visual fixation is achieved and maintained in moving visual
surrounds or with movements of the observer. Finally, a question
persists as to whether "conflict" neurons exist, and, if so, where?
2. Research suggestions
Because of the large amount of essential biologic
data that must be acquired to provide the basis for a practical
understanding of motion and space sickness, the Working Group
suggests that a long-term, broad-based program of basic research
is needed to unravel the complexly interconnected neural circuits
and to elucidate the intricate biologic mechanisms involved.
Examples follow of the types of investigations that are considered
advisable.
Identification of neuronal circuits in the vestibular
nuclei and the vestibular centers of the cerebellum, their connec-
tions to the emetic control mechanism, and their roles in motion
sickness needs greater emphasis. Where practical, natural stimuli
should be used in studies of sensory interactions to trace the pro-
jections of afferent neurons of the spatial end organ receptors to
the vestibular nuclei and their connections with second order neu-
rons. Identified pathways converging back on secondary neurons
should be included with such studies.
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A plan should be developed for (i) neuronal mapping of
areas of the brain that are considered to be primarily responsive
to motion sickness stimuli; (2) identification and characteriza-
tion of the neurotransmitters, neuromodulators, and receptors in
the mapped pathways and connections; and (3) determination of the
function of the identified pathways and connections and their role
in the habituation to motion and space sickness.
An important approach to the improvement of medicinal man-
agement of space sickness and to aid in the discovery of more
effective drugs is determining sites of drug action. For instance,
Wamsley et al. (1981) demonstrated high densities of muscarinic
receptors in the medial vestibular nuclei in the rat. They used
radiolabeled quinuclidinyl benzilate ([3H]ONB) and autoradiograpy
of selected sections of the brain stem in these light microscopic
studies. A similar study from the same laboratory identified large
concentrations of histamine-H 1 receptors in the medial vestibular
nuclei (Palacios et al., 1981). These studies are of considerable
interest because such drugs as scopolamine, an anticholinergic,
and dimenhydrinate, an antihistaminic, may mediate their anti-
motion sickness effect via the identified receptors in the medial
vestlbular nuclei. Also, different kinds of muscarinic receptors
have been identified. Precise pharmacologic definition of the
types of receptors in the vestibular nuclei could suggest new anti-
motion sickness drugs.
Thus, identification of neurotransmitters and neurorecep-
tors in relevant areas of the brain could lead to a new pharmaco-
logic approach to space sickness. More effective drugs, with
fewer side-effects, seem highly desirable and may already exist in
untested inventories of drug companies.
Other studies are needed to determine whether the link
from the vestibulocerebellar axis into the emetic reflex arc in
motion sickness is neuronal, chemical, or both.
Hypotheses should be formulated on which to base experi-
ments to examine the interactions among vestibular, visual, pro-
prioceptive, and somatosensory inputs resulting from motion expo-
sures associated with terrestrial and space motion sickness.
Other experiments should be devised to provide neuronal activity
recordings from selected cerebellar sites during the process of
habituation to motion stimuli. For example, unit recordings in
the uvula and nodulus during motions that are known to cause sick-
ness might prove worthwhile. Also, the input and output activi-
ties of the regions of the uvula, nodulus, and flocculus should be
determined in response to motion stimuli and related, if possible,
to activity in the vestibular nuclei. In addition, the feasi-
bility of determining susceptibility to motion sickness of human
subjects having congenital cerebellar cortical degeneration should
be explored.
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With respectto the sensoryconflicthypothesis,studies
are needed on the interactions of visual signals with the cerebel-
lum and the vestibular nuclei as an approach to understanding the
processing of conflicting sensory information. For example, the
relationship between visual suppression in a moving environment
and neuronal responses in the vestibular nuclei should be examined.
Aspects to be studied might include (i) eye position mechanisms
for stabilizing images; (2) neural pathways related to ocular pur-
suit; and (3) associated long-term storage mechanisms that enhance
the low-frequency characteristics of the vestibuloocular reflex.
A related question concerns how the velocity signal induced by
head movements is formed and how such long-lasting processes are
integrated within the nervous system. Finally, experiments are
needed to identify relationships and mechanisms between levels of
alertness and responses to motion stimuli at the level of the
vestibular nuclei.
D. METHODOLOGY
i. Assessment
The Working Group took note of the availability of
an array of research methods in neuroanatomy, neurophysiology, and
neurochemistry that have evolved in recent years, such as those
described by Brizzee and Dunlap (1982; 1983) and in the 1978-1982
short course syllabi of the Society for Neuroscience*. Few reports
of interest to the problems of space sickness have appeared in
which the newer technics and methods were employed. Examples of
some neuroanatomical methods are: the 2-deoxyglucose technic
(Sokoloff et al., 1977); immunocytochemical technics (Jones and
Hartman, 1978); horseradish peroxidase double labeling (Rustioni,
1978); and electron microscopic autoradiographic methods
(Hendrickson, 1978). For neurophysiologic investigations, an
emerging technic has been termed "neurokinesiology," a method for
investigating correlations between behavioral observations and
recorded neural activity in a chronic preparation (Loeb, 1979).
Extracellular single-unit recording permits studies of the
responses of central neurons to sensory stimuli in alert, moving
animals (Humphrey, 1979). One useful noninvasive method for
assessing intracranial events such as changes in blood flow and
neural activity is positron emission tomographic scanning (PET
scanning) (Phelps et al., 1982). (Other examples are noted on
P.37).
* 9650 Rockville Pike, Bethesda, MD 20814.
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As a general principle, research and development on
methods should be emphasized when they show promise of aiding the
advance of research in basic problems of motion sickness, in par-
ticular the elucidation of underlying mechanisms.
The problem of finding the most appropriate animal model,
or models, was discussed, with emphasis on the need to continue a
search for suitable animal models that offer advantages not only
in physiologic response, but also of availability, cost, and ease
of handling. Thus far, animals that most closely match humans in
terms of responses to motion and anti-motion sickness drugs are
cats, dogs, and squirrel monkeys. Animal models such as rats and
other species that do not vomit, do however, exhibit certain
visceral signs of sickness such as salivation. Whether such
thoroughly studied and relatively inexpensive species have a good
potential in studies of motion and space sickness needs further
consideration.
Functional tests of the vestibular apparatus fall short
of ideal; for instance, there is currently no dynamic test for
otolith function in humans. There is no clear test of the ver-
tical semicircular canals. Counter-rolling, a static test of
otolith function, is less than optimal. A need exists for a set
of functional tests for assessment of all the "spatial" receptor
organs and their interactions. The possibility of a vestibular
brain stem evoked potential (Aran et al., 1980; Elidan et al.,
1982) is appealing.
A recurring question is the utility of parabolic flight
in aircraft for studying space sickness. While this method is the
only one short of space flight that can produce more than momentary
weightlessness, its practical utility for resolving problems of
space sickness should be reconfirmed if possible.
Finally, a question arose concerning possible utility of
the clinostat as a means of simulating some aspects of zero-G for
studies of vestibular responses (for review, see Gordon and Shen-
Miller, 1971). Members of the Working Group did not consider that
the clinostat offers a valid method of simulating weightlessness
for investigations of space sickness. However, devices for tilting
experimental subjects in pitch and roll have proved valuable in
characterizing physiologic responses of the otolith organs (for
example, Fernandez and Goldberg, 1972; 197@).
2. Research suggestions
The neurochemistry of selected anatomic sites in the
putative nauseogenic and emetic reflex arcs of motion sickness
should be studied to identify and characterize all chemoreceptors
and neurotransmitters involved. Methods are needed for determining
whether neurotransmitters that are functionally specific in the
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emetic and nauseogenic reflex arcs are released at the defined
sites and the time course and nature of the release. The prelimi-
nary work on the existence of a vomiting substance (Daunton, 1982)
should be extended to confirm its existence and to charactize it.
Therapeutic counteraction or inactivation may then be feasible.
For determining the sensitivities to inhibitory or
blocking agents of active sites in the emetic reflex arc of motion
sickness, a promising method is by injection of drugs via implanted
cannulas before, during, and after exposure of the test animal to
sickness-inducing motion stimuli. Theoretically, neurochemicals
with apparent selectivity for motion sickness in implicated path-
ways would be targets for pharmacologic intervention.
Some of the newer technics that show promise for helping
to identify and characterize receptor sites in the nervous system
include the radioreceptor assay (Enna, 1980); in vivo receptor
binding of radiolabeled drugs combined with light microscopic
autoradiography (Palacios et al., 1981); in vitro autoradiography
(Young and Kuhar, 1979); and combinations of such technics with
other methods such as fluorescence histochemistry (Roth et al.,
1974) or immunocytochemistry (Jones and Hartman, 1978).
Resolution of the autoradiographic and other methods used
to locate receptor binding sites in the nervous system is inadequate
for precise localization. For instance, electron microscopic auto-
radiographic processes have a limit of resolution of approximately
1500 Angstrom units, which is larger than a synapse (Murrin,
1980). Promising electron microscopic technics include use of
peroxidase labeled ligands or antibodies to purified receptors
(Vogel et al., 1979).
Sequential double-labeling technics have been helpful in
identifying and studying sites in the brain stem that take up glu-
cose differentially while the test subject is exposed to motion
stimuli. (For example, see: Agranoff et al., 1980; Altenau and
Agranoff, 1978; Brizzee and Dunlap, 1982, 1983). These and other
methods should be refined to enable identification of neural path-
ways that mediate motion sickness stimuli and may be involved in
habituation.
Efforts should be extended to develop alternate methods
of testing otolith organ function and a spectrum of tests to
assess all the receptor organs and their interactions. Such a
group of tests should aid in identifying individuals who are sus-
ceptible as well as those who are resistant to motion sickness.
It may be feasible to develop procedures for measuring brain stem
vestibular evoked potentials (Aran et al., 1980; Elidan et al.,
1982). It would seem useful to explore neural correlates of sen-
sory conflict by measuring the difference between eye movements
and patterns of firing rates under certain conditions in which
there is a mismatch between visual and vestibular stimuli.
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The search for the most suitable animal models for
studies of terrestrial and space motion sickness should be con-
tinued. Objective methods of determining the occurrence of motion
sickness in experimental animals, in addition to vomiting, should
be applied to animals in which the vomiting response is absent or
unreliable. Further investigation of the vegetative responses of
rodents, birds, and amphibia to motion stimuli may be advisable to
determine whether these species demonstrate a measurable end point
that could make them useful for motion sickness studies and for
screening anti-motion sickness drugs (Coil et al., 1978; Hulse
et al., 1977; Mitchell et al., 1977a,b; Ossenkopp, 1982). In addi-
tion, genetic mutants (pallid mice) exist that lack otoconia, and
may offer a useful model for studying chronic otoconial deficiency
(Lim and Erway, 1974).
A useful method for the in vitro study of various neu-
ronal factors including the effects of drugs and hormones is the
electrophysiological slice technic (Prince and Wang, 1981; Skrede
and Westgaard, 1971).
With regard to the fluid shift hypothesis of space sick-
ness, the question of possible circulatory influences on the com-
position of the endolymph and its role in the micromechanics of
transduction should be investigated. Methods are needed to simu-
late postulated changes in intracranial blood pressures and flows
(Soffen and Gazenko, 1981) associated with zero-G. Centrifuges
offer a means of increasing or decreasing intracranial blood pres-
sure, as may pressor agents, vasodilators, and diuretics. Neural
elements controlling vessels supplying the labyrinth should be
identified and studied. In addition, studies should be done on
the effects of altered blood supply on the ionic and nutritive
milieu of such intralabyrinthine structures as the apical tips of
hair cells, stereocilia, kinocilia, and cupula and otonial mem-
brane. However, this may be a difficult area of study for which
currently available methods may be inadequate.
Whenever feasible, opportunities should be provided for
behavioral scientists involved in studies of motion sickness, such
as those engaged in autogenic (biofeedback) training methods, to
interact with neuroscientists and other scientists in basic and
applied aspects of motion sickness research. Joint participation
in research planning, workshops, symposia, and collaborative
effort in actual research projects should be encouraged.
A new method of measuring motion perception in space is
through the use of the illusion of movement when targets are
illuminated by flashing lights (Sigma movement). (For an example,
see Adler et al., 1981). This technic is useful for demonstrating
the presence of internal feedback mechanisms that signal and
sustain the illusion of target movement.
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Finally, as a guiding principle to improve the fidelity
of physiologic responses in motion sickness studies, the ad hoc
Working Group suggests that experimental stimuli should be within
physiologic limits when possible and tests should be conducted
humanely in unanesthetized, alert animals.
E. COUNTERMEASURES AND OTHER ASPECTS
I. Assessment
The ad hoc Working Group is aware of the vigorous
planning efforts accomplished by NASA to produce an accelerated
program of research and analysis in space motion sickness, and
that the development and test of countermeasures are understand-
ably being accorded a high priority. Because the Working Group
was requested to consider the problem mainly from the viewpoint of
basic research, only a few aspects of countermeasures were dis-
cussed. It is assumed that such logical-appearing measures as
developing means of identification of susceptible and tolerant
individuals, means of preflight habituation, means of self-control
of symptoms of motion sickness, inflight enhancement of habitua-
tion, and improved drug intervention will continue to receive
strong NASA support. It is possible that better anti-motion sick-
ness drugs may already exist in the untested inventories of some
drug companies.
On the other hand, it seems generally agreed that the
knowledge of the underlying mechanisms of motion and space sick-
ness that should ultimately come from the basic research program
is fundamental to the development of the most effective means of
preventing or controlling space sickness.
A key question on drug intervention is where and by what
practical clinical means can neuronal circuits that have been
shown to be essential to the generation of motion sickness be
inhibited or blocked. Although progress has been made in locating
in the brain stem, receptor sites for certain anti-motion sickness
drugs, the actual site of action of scopolamine, for example, is
unknown. Some of the newer technics of neuroscience offer opportu-
nities for significant progress in this area.
A question arose during the ad hoc meeting about the reli-
ability of the Shuttle Orbiter environmental control system for
keeping the cabin air within acceptable limits for possible toxic
contaminants, certain of which have the ability to induce nausea
and vomiting. It is understood that, at present, samples of the
cabin air are collected periodically inflight for postflight anal-
ysis; further, that NASA expects to have the capability for auto-
matic, real time monitoring of cabin air in future missions of the
Shuttle Orbiter. No evidence of any problem with the breathing
atmosphere of the Shuttle Orbiter came to the attention of the
Working Group.
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Discussion of the experiments of Bard et al. (1947) and
Tyler and Bard (1949) on the prevention of swing sickness in dogs
whose noduli and uvuli had been ablated raised the question of
whether the interruption of these cerebellar connections as an
experimental technic of preventing swing sickness was generalizable
to other types of motion stimuli known to induce motion sickness.
The methods NASA uses to report the effects of space
flight on the astronauts and the results of inflight experiments
were discussed. It was concluded that improvements are needed to
assure wider dissemination of such data on a more timely schedule.
An important part of management of the program is informing the
scientific community about NASA's research needs in order to stimu-
late sufficient interest to generate proposals from highly competent
scientists. One means of doing this is to publish in a scientific
journal widely read by biomedical scientists, an account of the
important unknown or poorly understood aspects of space sickness
and suggested research approaches to gain the desired knowledge.
2. Research suggestions
Until enough is known about specific sites in reflex
arcs to permit more precise pharmacologic intervention, development
and test of candidate anti-motion sickness drugs should be continued
in an effort to formulate and characterize more effective drugs with
fewer side-effects. With regard to delivery systems, special notice
should be taken by NASA scientists and operational flight surgeons
of the occasional report of prolonged mydriasis in patients using
transdermal scopolamine (Carlston, 1982; Chiaramonte, 1982; Lepore,
1982; McCrary and Webb, 1982; Roper and Hale, 1982).
Consideration should be given to repeating the experiments
of Tyler and Bard (1949) on prevention of swing sickness in dogs
by ablation of the uvula and nodulus. If possible, the experimental
protocol should be refined in order to help define more accurately
the pathways involved in mediating motion sickness. In addition,
other types of motion stimuli should be used in such experiments to
determine whether the effect of ablation of these cerebellar connec-
tions is generalizable to different sickness-inducing motions. Use-
ful data on the function of the nodulus and uvula in motion sickness
might be derived from electric or chemical stimulation of these parts
of the cerebellum.
Repeated parabolic flights scheduled for the days immedi-
ately preceding a spaceflight may facilitate habituation to stimuli
associated with zero-G, and such exposures should offer an approach
to prediction of individiual responses to weightlessness.
The results of analyses of the cabin air samples of the
Shuttle Orbiter might be reexamined to confirm the absence of any
toxic contaminant, such as trichloroacetylene, that could be respon-
sible for signs or symptoms associated with space sickness. With
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regard to a need for improving the dissemination of information on
the effects of space flight on the astronanuts and on the results
of inflight experiments, NASA should review its current procedures
and consider the feasibility and desirability of increasing the
publication of biomedical papers in widely read scientific journals.
Brief technical notes that could be published with minimal delay as
well as more complete reports in customary scientific format would
improve the process of informing the scientific community, which,
in turn, should stimulate wider interest in NASA's biomedical
problems.
Available data on the effects of aging on the integrity
of the vestibular system and on motion sickness susceptibility and
ability to habituate should be examined to determine possible needs
for additional studies.
In view of the potential scope and size of a comprehensive
research program of neuronal mapping, functional determination of
pathways, and identification and characterization of neurotrans-
mitters, neuromodulators, and receptors, available hypotheses and
models should be refined if possible and new hypotheses developed
in order to focus needed research into manageable packages. The
implied dimensions of such a comprehensive effort suggest that a
collaborative effort by a number of cooperating laboratories would
be advantageous.
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Vl. PRIORITIES FOR RESEARCH AND ANALYSIS
The main objective of the NASA ground-based research and
analysis program is to determine the cause(s) and underlying bio-
logic mechanisms of space sickness. This objective includes
improvement of investigative technics, methods, equipment, and
facilities, and development of effective prophylactic and thera-
peutic countermeasures. The ad hoc Working Group on Space Motion
Sickness was concerned primarily with basic research and asso-
ciated methodology. The high priority accorded the development
and test of improved countermeasures to deal with the problem,
such as improved means of pharmacologic intervention, is under-
stood as being operationally essential for NASA. However, the
primary basis for progress in prevention and treatment is
knowledge of the true etiology and underlying mechanisms of the
disorder, achievement of which requires a sustained, broad-based
research program. NASA's current and planned research in this
field, augmented by the suggestions of the ad hoc Working Group,
should ultimately provide the knowledge needed for solution of the
problem.
As a general approach, a program should be planned to map
areas of the brain thought to be involved in space and motion sick-
ness and to identify and characterize the associated chemoreceptors,
neurotransmitters, and neuromodulators. Related studies should
probe the roles of the identified pathways and regulatory substances
in the mediation of, and habituation to, space and motion sickness
and as leads for discovering new drugs.
The ad hoc Working Group recommends the order of priority
shown in Table 5 as appropriate for the suggested research and
development in this problem area. The suggestions in the category,
"Stimulus-Response Relationships," are considered most important;
those in the second group, "Reflex Pathways," should be next in
priority, followed by those in "Related Vestibular Neurophysiology."
However, if future studies confirm the essentiality of the vesti-
bular apparatus in the mediation of space sickness, studies of its
neurophysiology will assume major importance.
Not all the research suggested in Section V is high-
lighted in Table 5; for example, most of the suggestions on method-
ology and countermeasures appear only in Section V. However, this
does not imply that items not shown in the table are unimportant.
Several matters that were considered worthy of special emphasis by
the WorKing Group are reiterated here. One involves the desirability
of exploiting the newer investigative methods of neuroscience when
designing future experiments (see p.35, 37). Another is a need to
develop alternate animal models, hopefully including species lower
in the phylogenetic scale than cats, dogs, or monkeys, in which
objective end points can be used for the study of space and motion
sickness (see p.38). Such models may offer additional advantages
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Table 5. Proposed Order of Priority of Research Suggested by the
ad hoc Working Group on Space Motion Sickness*
STIMULUS-RESPONSE RELATIONSHIPS
• Delineate quantitatively the essential characteristics of
the disorder with respect to environmental circumstances,
symptomatology, and time course.
• Determine with certainty the indispensability of the
vestibular apparatus as the key sensory element in space
sickness.
REFLEX PATHWAYS
• Evaluate neuronal circuits in the vestibular nuclei and the
vestibular centers of the cerebellum in mediating space and
motion sickness and as a confirmation of the early experiments
described by Tyler and Bard (1949).
• Confirm the role of the chemoreceptor trigger zone in the
central emetic circuit.
• Explore neuronal elements of the vestibulo-cerebellar circuits
for changes in electrophysiologic activity relating to
habituation.
o Study the participation and functional specificity of chemical
mediators at transmission points in the vestibulo-cerebellar-
emetic circuit and possible modifying factors such as efferent
input.
• Explore the relationship between space sickness and arousal
mechanisms.
• Study interactions of vestibular and visual signals in the
vestibular and cerebellar muclei as an approach to exploring
the theories of sensory mismatch or conflict.
• Examine the interactions among vestibular, proprioceptive,
visual, and somatosensory inputs recruited in the genesis of
space sickness.
* Listed in order of decreasing priority in each of three categories
shown. For detail, see Section V, A-F.
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Table 5. (cont.)
RELATED VESTIBULAR NEUROPHYSIOLOGY
If the vestibular apparatus proves to be essential in the
induction of space sicknes, the studies of its neurophysiology
will assume major importance.
o Study the sensitivity of the semicircular canals to linear
acceleration in the alert, chronic normal preparation, and
relate this to space and motion sickness.
o Investigate in the alert preparation the relationship between
afferent vestibular neuronal activity and efferent activity in
situations in which the efferent system may participate.
o Explore circulatory factors regulating endolymph composition
and function as these may affect vestibular function.
o Investigate the reported presence and functional significance
of some species of postganglionic autonomic nerve fibers in
various elements of the vestibular apparatus such as the vesti-
bular nerve and terminals around vessels in the labyrinth.
o Identify and characterize at the single unit level, the afferent
input from the vestibular organs resulting from complex motion
stimuli such as cross-coupled accelerations.
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in terms of availability and for possible large volume drug screening.
The desirability of conducting studies in unanesthetized, alert
animals was also noted.
There is a need to focus on studies of the cellular
mechanisms in the peripheral end organs such as the mechano-
electrical transduction process of hair cells and the biochemistry
and neurophysiology of the adaptation mechanisms in the sensory
neuroepithelium. Attention should be aimed, as well, at lower
brain stem structures and final common pathways, perhaps via
intensive studies of the vestibular cortex and vestibular thalamus
in relation to space and motion sickness.
Finally, at the agency policy-making level, three sugges-
tions of the Working Group should be highlighted. First, it might
be appropriate to stage a recruiting drive to train the next gener-
ation of investigators for work in those disciplines that are
germane to the study of space sickness. Second, the advisability
should be considered of establishing an advisory group to continue
the task of the present ad hoc Working Group on Space Motion Sick-
ness until sufficient progress will have been made for satisfactory
solution. And last, NASA should endeavor to improve its systems
for wide and timely dissemination of biomedical data from its
research programs, including the flight program. Increased publi-
cation in widely read scientific journals might be one objective.
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